Janus kinase inhibitors can be paired with corticosteroids or used as monotherapy in the treatment of alopecia areata.

Zoryve’s regulatory and commercial success, together with pipeline progress, supports Arcutis Biotherapeutics’ positive Q2 ...

The FDA has granted a “Fast Track” designation to rezpegaldesleukin (REZPEG) as a treatment for severe-to-very severe ...

The UP-AA clinical program includes 2 studies assessing the safety and efficacy of upadacitinib in adults and adolescent patients with severe alopecia areata.

AbbVie released positive topline data from its phase 3 UP-AA trial demonstrating safety and efficacy for upadacitinib for ...

A bbVie has reported encouraging topline outcomes from the first of two replicate trials of the Phase III UP-AA programme, ...

Medically reviewed by Susan Bard, MD Losing hair due to alopecia can be a distressing experience, and it’s common to wonder if hair regrowth is possible, but the answer to that varies depending on the ...

As Women with Alopecia Awareness Month comes to a close, WRBL spoke to a local woman impacted by the autoimmune condition.

Alopecia areata, an autoimmune disorder causing hair loss, now has an FDA-approved treatment since June 2022. While some ...

New treatment for teens with alopecia The FDA approved the once-daily pill called Litfulo, created by pharmaceutical giant Pfizer, for people 12 and up to treat severe alopecia areata, or at least ...

Until now. The FDA has approved what experts are calling a groundbreaking treatment for severe alopecia areata, making it the only medication on the market approved for the skin disease. 0:00 1:28 ...

Amy J. McMichael, MD Disclosures February 27, 2003 0 Question Are there any new therapies for the treatment of alopecia areata? Anthony E. Campbell, MD Response from Amy J. McMichael, MD ...